Subantimicrobial dose doxycycline improves clinical healing
According to the research, chronic inflammatory diseases like periodontitis might accelerate vascular disease and promote thrombosis. Both periodontal bacteria and the cytokines produced from periodontal inflammation can enter the blood stream and trigger changes associated with heart disease. For example, cytokines can breakdown the thin collagen cap covering cholesterol-rich plaques lining blood vessels, causing them to rupture, resulting in thrombosis.
Researchers at Gazi University in Ankara, Turkey, designed the first study to evaluate the effects of scaling and root planing (SRP) and subantimicrobial dose doxycycline (SDD) on a group of 36 subjects all having both chronic periodontitis and coronary artery disease. All of them were taking statin drugs. All subjects received SRP once a week for two weeks with both hand- and power-instruments. Half the group took a 20mg. SDD, and the other half took an identical appearing placebo twice daily for six weeks.
Blood and crevicular fluid samples taken at baseline and six weeks compared levels of cytokines and cholesterol, showing similar reductions for both test and control groups. Proteins of collagenase and gelatinase were measured rather than direct enzyme activity, therefore the proportion of active to inactive enzymes in these samples is unknown. In other studies measuring enzyme activity, SDD added to SRP results in greater reductions than measure in this study.
Clinical indices showed improvement for both groups but greater improvement was measured for those receiving SDD, especially for probing depths and gingivitis.
Clinical Implications: Preliminary findings suggest that taking subantimicrobial dose doxycycline along with scaling and root planing results in better periodontal healing and reduced cholesterol levels in patients with heart disease. Larger studies are needed to confirm these findings.
Tüter, G., Kurtis, B., Serdar, M., Aykan, T., Okyay, K., Yücel, A., Toyman, U., Pinar, S., Cemri, M., Cengel, A., Walker, S., Golub, L.: Effects of Scaling and Root Planing and Sub-Antimicrobial Dose Doxyclycline on Oral and Systemic Biomarkers of Disease in Patients with both Chronic Periodontitis and Coronary Artery Disease. J Clin Perio 34: 673-681, 2007.
|
Chlorhexidine toothpaste tested
Since toothbrushing is the most common oral hygiene method, toothpaste seems to be the best way to deliver a chemical to the oral cavity for controlling plaque and gingivitis. Chlorhexidine was not added to toothpaste for fear of interactions with sodium lauryl suphate (SLS) and competition for oral retention sites. Case studies have been published showing the effectiveness of a new formulation available in Germany called Lacalut. After just a few days, this toothpaste has been reported to reduce clinical signs of acute and chronic gingivitis.
Researchers at Albert-Ludwigs University in Freiburg, Germany, designed a six-month study to compare this chlorhexidine, aluminum lactate containing toothpaste to a similar formulation without these ingredients. Both formulations contained aluminum fluoride.
Subjects were evaluated at baseline, one, three and six months. Gingivitis scores were recorded on the six Ramfjord teeth, calculus scores on the lingual surfaces of the mandibular anterior teeth, and stain scores for the buccal surfaces of the maxillary and mandibular anterior teeth. A total of 60 patients began the study and only one dropped out of the study.
Plaque and gingivitis scores were similar at three months, probably due to the Hawthorne Effect. Between three and six months, a greater reduction in the gingival index was observed for the chlorhexidine toothpaste group. This might be due to the astringent effect of the aluminum lactate on the tissues, since plaque levels were not reduced. Minimal stain and calculus were noted for both groups at the end of the study.
The researchers speculated that the chlorhexidine might have been inactivated by the SLS. The low calculus and stain scores would support this conclusion.
Clinical Implications: This chlorhexidine toothpaste formulation provided no added benefit for reducing plaque and gingivitis, but we might see other formulations in the future that overcome the effects of SLS.
Rathe, F., Auschill, T., Sculean, A., Gaudszuhn, C., Arweiler, N.: The Plaque and Gingivitis Reducing Effect of a Chlorhexidine and Aluminium Lactate Containing Dentifice (Laculut Aktiv®) Over a Period of 6 Months. J Clin Perio 34: 646-651, 2007.
|